
Hedera-22
Offers all services related to the computational analysis of biological data.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | N/A | €600k Valuation: €5.0m | Seed |
Total Funding | 000k |
EUR | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | 109 % | (45 %) | 44 % |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
% profit margin | (31 %) | (63 %) | (268 %) | (177 %) |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Hedera 22 is at the forefront of biomolecule discovery, leveraging a unique technology platform to enhance the output, diversity, and maturity of cryptic metabolites. The company serves the agricultural market, addressing significant challenges with sustainable biopesticides. Hedera 22's business model revolves around its proprietary machine learning algorithms, which integrate genome mining, metabolomics, and structure prediction to rapidly identify next-generation compounds. This approach not only streamlines the discovery process but also builds an extensive, patentable molecule library. The company generates revenue by developing and licensing these innovative compounds to agricultural firms seeking eco-friendly solutions. Hedera 22's clients include research scientists in molecular and synthetic biology, particularly those with expertise in cell-free expression or recombinant protein expression. The company's market is primarily focused on sustainable agriculture, aiming to provide natural product-based solutions to enhance crop protection and productivity.
Keywords: biomolecule discovery, genome mining, machine learning, sustainable agriculture, biopesticides, metabolomics, structure prediction, patentable molecules, eco-friendly solutions, agricultural innovation.